NYSE · Pharmaceutical Preparations
326 entities across 61 jurisdictions, 11 in offshore financial centres. Read directly from the company’s own 10-K EX-21 filed 2026-02-24 — see the exhibit.
| Entity | Jurisdiction | Note |
|---|---|---|
| Canada Inc. | Canada | |
| Abceutics, Inc. | Delaware | |
| Abmaxis Inc. | Delaware | |
| Acceleron Pharma Inc. | Delaware | |
| Afferent Pharmaceuticals, Inc. | Delaware | |
| Agrident GmbH | Germany | |
| Allflex Argentina S.A. | Argentina | |
| Allflex Australia Pty. Ltd. | Australia | |
| Allflex (China) Intelligent Technology Co. Ltd. | China | |
| Allflex Dan-Mark ApS | Denmark | |
| Allflex Europe S.A.S. | France | |
| Allflex Group Germany GmbH | Germany | |
| Allflex India Private Limited | India | |
| Allflex Maroc S.A.R.L. | Morocco | |
| Allflex New Zealand | New Zealand | |
| Allflex Polska Spolka z ograniczona odpowiedzialnoscia | Poland | |
| Allflex Romania S.R.L. | Romania | |
| Allflex UK Group Limited | United Kingdom | |
| Allflex USA LLC | Delaware | |
| Animal Health Registration World Wide (Proprietary) Limited | South Africa | |
| ArQule, Inc. | Delaware | |
| Biomark LLC | Idaho | |
| Burgwedel Biotech GmbH | Germany | |
| Calporta Therapeutics, Inc. | Delaware | |
| Canji, Inc. | Delaware | |
| Caraway Therapeutics Inc. | Delaware | |
| Caymus Purchaser, Inc. | Delaware | |
| cCam Biotherapeutics Ltd. | Israel | |
| Cherokee Pharmaceuticals LLC | Delaware | |
| Controladora MSD Mexicana Sociedad de Responsabilidad Limitada de Capital Variable | Mexico | |
| Cooper Veterinary Products (Proprietary) Limited | South Africa | |
| Corporation Allflex ULC | Canada | |
| Cosmas B.V. | Netherlands | |
| Cubist Pharmaceuticals LLC | Delaware | |
| Dialstat Trading 91 Pty Ltd T/A Allflex SA | South Africa | |
| Diosynth Holding B.V. | Netherlands | |
| Diosynth Produtos Farmo-quimicos Ltda. | Brazil | |
| Elastec S.R.L. | Argentina | |
| Essex Pharmaceuticals, Inc. | Philippines | |
| Eyebiotech Inc. | Delaware | |
| Farmacox - Companhia Farmaceutica, Sociedade Unipessoal, Lda. | Portugal | |
| Farmasix-Produtos Farmaceuticos, Sociedade Unipessoal, Lda. | Portugal | |
| Financiere MSD | France | |
| Fontelabor-Produtos Farmaceuticos, Sociedade Unipessoal, Lda. | Portugal | |
| Frosst Laboratories, Inc. | Delaware | |
| Frosst Portuguesa - Produtos Farmaceuticos, Sociedade Unipessoal, Lda. | Portugal | |
| GlycoFi, Inc. | Delaware | |
| Hangzhou MSD Pharmaceutical Co., Ltd. 1 | China | |
| Harpoon Therapeutics Inc. | Delaware | |
| Harrisvaccines LLC | Iowa | |
| Hawk and Falcon L.L.C. | Delaware | |
| Heptafarma Companhia Farmaceutica, Sociedade Unipessoal, Lda. | Portugal | |
| Hydrochemie GmbH | Germany | |
| Idenix GmbH | Switzerland | |
| IdentiGEN Limited | Ireland | |
| Imago Biosciences, Inc. | Delaware | |
| Immune Design Corp. | Delaware | |
| International Indemnity Ltd. | Bermuda | offshore centre |
| Intervet (Ireland) Limited | Ireland | |
| Intervet (Israel) Ltd. | Israel | |
| Intervet (M) Sdn. Bhd. | Malaysia | |
| Intervet (Proprietary) Limited | South Africa | |
| Intervet (Thailand) Ltd. | Thailand | |
| Intervet Agencies B.V. | Netherlands | |
| Intervet Animal Health Taiwan Limited | Taiwan | |
| Intervet Arabia Limited | Saudi Arabia | |
| Intervet Argentina S.A. | Argentina | |
| Intervet Australia Pty Limited | Australia | |
| Intervet Canada Corp. | Canada | |
| Intervet Central America S. de R.L. | Panama | offshore centre |
| Intervet Deutschland GmbH | Germany | |
| Intervet Egypt for Animal Health SAE | Egypt | |
| Intervet GesmbH | Austria | |
| Intervet Hellas M.A.E. | Greece | |
| Intervet Holding B.V. | Netherlands | |
| Intervet Holdings France SAS | France | |
| Intervet Hungaria Értékesítő Kft | Hungary | |
| Intervet Inc. | Delaware | |
| Intervet India Private Limited | India | |
| Intervet International B.V. | Netherlands | |
| Intervet International GmbH | Germany | |
| Intervet International Sarl | France | |
| Intervet Maroc S.A. | Morocco | |
| Intervet Mexico S.A. de C.V. | Mexico | |
| Intervet Middle East Limited | Cyprus | offshore centre |
| Intervet Nederland B.V. | Netherlands | |
| Intervet Philippines, Inc. | Philippines | |
| Intervet Productions S.A. | France | |
| Intervet Productions S.r.l. | Italy | |
| Intervet Romania SRL | Romania | |
| Intervet SAS | France | |
| Intervet Schering-Plough Animal Health Pty. Ltd. | Australia | |
| Intervet South Africa (Proprietary) Limited | South Africa | |
| Intervet Sp. z.o.o. | Poland | |
| Intervet UK Production Limited | United Kingdom | |
| Intervet Veterinaria Chile Ltda | Chile | |
| Intervet Veteriner Ilaclari Pazarlama ve Ticaret Ltd. Sirketi | Turkey | |
| Intervet, s.r.o. | Czech Republic | |
| Interveterinaria SA de CV | Mexico | |
| IOmet Pharma Limited | Scotland | |
| Laboratoires Merck Sharp & Dohme – Chibret | France | |
| Laboratorios Abello, S.A. | Spain | |
| Laboratorios Quimico-Farmaceuticos Chibret, Sociedade Unipessoal, Lda. | Portugal | |
| Maya Tibbi Ürünler Ticaret Limited Sirketi | Turkey | |
| MCM Vaccine B.V. 1 | Netherlands | |
| Merck and Company LLC | Delaware | |
| Merck Canada Inc. | Canada | |
| Merck Capital Ventures, LLC 1 | Delaware | |
| Merck Frosst Canada & Co. | Canada | |
| Merck Frosst Company | Canada | |
| Merck Global Health Innovation Fund, LLC | Delaware | |
| Merck Global Health Innovation, Private Equity, LLC | Delaware | |
| Merck HDAC Research, LLC | Delaware | |
| Merck Holdings II Corp. | Delaware | |
| Merck Holdings IV Corp. | Delaware | |
| Merck Holdings V LLC | Delaware | |
| Merck Holdings LLC | Delaware | |
| Merck Lumira Biosciences Fund L.P. 1 | Canada | |
| Merck Registry Holdings, Inc. | New Jersey | |
| Merck Research Investments LLC | Delaware | |
| Merck Research Laboratories Massachusetts, LLC | Delaware | |
| Merck Sharp & Dohme (Argentina) LLC | Delaware | |
| Merck Sharp & Dohme (Asia) Limited | Hong Kong | |
| Merck Sharp & Dohme (Australia) Pty. Limited | Australia | |
| Merck Sharp & Dohme (Chile) Ltda. | Chile | |
| Merck Sharp & Dohme (Enterprises) B.V. | Netherlands | |
| Merck Sharp & Dohme (Holdings) Pty Ltd | Australia | |
| Merck Sharp & Dohme (I.A.) LLC | Delaware | |
| Merck Sharp & Dohme (International) Limited | Bermuda | offshore centre |
| Merck Sharp & Dohme (Israel - 1996) Company Ltd. | Israel | |
| Merck Sharp & Dohme (Malaysia) SDN. BHD. | Malaysia | |
| Merck Sharp & Dohme (New Zealand) Limited | New Zealand | |
| Merck Sharp & Dohme (Sweden) A.B. | Sweden | |
| Merck Sharp & Dohme (Switzerland) GmbH | Switzerland | |
| Merck Sharp & Dohme (UK) Limited | United Kingdom | |
| Merck Sharp & Dohme Animal Health, S.L. | Spain | |
| Merck Sharp & Dohme Asia Pacific Services Pte. Ltd. | Singapore | |
| Merck Sharp & Dohme B.V. | Netherlands | |
| Merck Sharp & Dohme Colombia S.A.S. | Colombia | |
| Merck Sharp & Dohme Comercializadora, S. de R.L. de C.V. | Mexico | |
| Merck Sharp & Dohme Cyprus Limited | Cyprus | offshore centre |
| Merck Sharp & Dohme de España, SAU | Spain | |
| Merck Sharp & Dohme Farmaceutica Ltda. | Brazil | |
| Merck Sharp & Dohme Finance Europe Limited | United Kingdom | |
| Merck Sharp & Dohme Gesellschaft m.b.H. | Austria | |
| Merck Sharp & Dohme Holdings Corp. | Delaware | |
| Merck Sharp & Dohme Holdings LLC | Delaware | |
| Merck Sharp & Dohme IDEA GmbH | Switzerland | |
| Merck Sharp & Dohme International Services B.V. | Netherlands | |
| Merck Sharp & Dohme Ireland (Human Health) Limited | Ireland | |
| Merck Sharp & Dohme LLC | New Jersey | |
| Merck Sharp & Dohme Peru SRL | Peru | |
| Merck Sharp & Dohme Pharmaceutical, Trading Single member Societe Anonyme | Greece | |
| Merck Sharp & Dohme Research GmbH | Switzerland | |
| Merck Sharp & Dohme Romania SRL | Romania | |
| Merck Sharp & Dohme S.A. | Morocco | |
| Merck Sharp & Dohme s.r.o. | Czech Republic | |
| Merck Sharp & Dohme Salud Animal Perú S.A. | Peru | |
| Merck Sharp & Dohme Salud Animal Colombia S.A.S. | Colombia | |
| Merck Sharp & Dohme Saúde Animal Ltda. | Brazil | |
| Merck Sharp & Dohme Singapore Trading Pte. Ltd. | Singapore | |
| Merck Sharp & Dohme, Limitada | Portugal | |
| Merck Sharp & Dohme, S. de R.L. de C.V. | Mexico | |
| Merck Sharp Dohme Ilaclari Limited Sirketi | Turkey | |
| Merck Teknika LLC | Delaware | |
| Merko Acquisition S.A. | Belgium | |
| Merko Dalton B.V. | Netherlands | |
| Merko N.V. | Belgium | |
| ML Holdings (Canada) ULC | Canada | |
| Modifi Biosciences, Inc. | Delaware | |
| MRL San Francisco, LLC | Delaware | |
| MRL Ventures Fund LLC | Delaware | |
| MSD (Hainan) Innovative Healthcare Co., Ltd. | China | |
| MSD (I.A.) B.V. | Netherlands | |
| MSD (Ningbo) Animal Health Technology Co., Ltd. | China | |
| MSD (Norge) AS | Norway | |
| MSD (Proprietary) Limited | South Africa | |
| MSD (Shanghai) Pharmaceuticals Consultancy Co., Ltd. | China | |
| MSD (Thailand) Ltd. | Thailand | |
| MSD Agencies B.V. | Netherlands | |
| MSD Animal Health UK Limited | United Kingdom | |
| MSD Animal Health (Phils.), Inc | Philippines | |
| MSD Animal Health (Shanghai) Trading Co., Ltd. | China | |
| MSD Animal Health A/S | Denmark | |
| MSD Animal Health B.V. | Belgium | |
| MSD Animal Health Danube Biotech GmbH | Austria | |
| MSD Animal Health FZ-LLC | United Arab Emirates | |
| MSD Animal Health GmbH | Switzerland | |
| MSD Animal Health Holdings B.V. | Netherlands | |
| MSD Animal Health Innovation AS | Norway | |
| MSD Animal Health Innovation GmbH | Germany | |
| MSD Animal Health Innovation Pte. Ltd. | Singapore | |
| MSD Animal Health K.K. | Japan | |
| MSD Animal Health Korea Ltd. | Korea | |
| MSD Animal Health Norge AS | Norway | |
| MSD Animal Health Oy | Finland | |
| MSD Animal Health S.r.l. | Italy | |
| MSD Animal Health Sweden AB | Sweden | |
| MSD Animal Health Vietnam Company Limited | Vietnam | |
| MSD Animal Health, Lda. | Portugal | |
| MSD Argentina SRL | Argentina | |
| MSD Asia Holdings Pte. Ltd. | Singapore | |
| MSD BD-4 GmbH | Switzerland | |
| MSD Belgium BV – SRL | Belgium | |
| MSD Biotech B.V. | Netherlands | |
| MSD Central America Services S. de R.L. | Panama | offshore centre |
| MSD China (Investments) B.V. | Netherlands | |
| MSD China B.V. | Netherlands | |
| MSD China Holding Co., Ltd. | China | |
| MSD Cubist Holdings BV | Switzerland | |
| MSD Cubist Holdings Unlimited Company | Ireland | |
| MSD Czech Republic s.r.o. | Czech Republic | |
| MSD Danmark ApS | Denmark | |
| MSD Egypt LLC | Egypt | |
| MSD Eurofinance | Bermuda | offshore centre |
| MSD Europe Belgium SRL | Belgium | |
| MSD FI BV | Netherlands | |
| MSD Finland Oy | Finland | |
| MSD France | France | |
| MSD Global Holdings B.V. | Netherlands | |
| MSD Global Holdings 2 B.V. | Netherlands | |
| MSD HH Vietnam Ltd | Vietnam | |
| MSD Hyderabad Global Capabilities Center India Private Limited | India | |
| MSD Human Health Holding B.V. | Netherlands | |
| MSD Human Health Holding II B.V. | Netherlands | |
| MSD IDEA Pharmaceuticals Nigeria Limited | Nigeria | |
| MSD Innovation and Development GmbH | Switzerland | |
| MSD International B.V. | Netherlands | |
| MSD International Business GmbH | Switzerland | |
| MSD International Finance B.V. | Netherlands | |
| MSD International GmbH | Switzerland | |
| MSD International Manufacturing GmbH | Switzerland | |
| MSD Italia s.r.l. | Italy | |
| MSD Japan Holdings B.V. | Netherlands | |
| MSD Japan Holdings GK | Japan | |
| MSD K.K. | Japan | |
| MSD KSA GmbH | Switzerland | |
| MSD Korea Co., Ltd. | Korea | |
| MSD Laboratories India LLC | Delaware | |
| MSD Latin America Services S. de R.L. | Panama | offshore centre |
| MSD Latin America Services S. de R.L. de C.V. | Mexico | |
| MSD Limited | United Kingdom | |
| MSD Luxembourg S.a.r.l. | Luxembourg | offshore centre |
| MSD Merck Sharp & Dohme AG | Switzerland | |
| MSD Netherlands Capital B.V. | Netherlands | |
| MSD NL 4 B.V. | Netherlands | |
| MSD Panama International Services S. de R.L. | Panama | offshore centre |
| MSD Participations B.V. | Netherlands | |
| MSD Pensions Trustee Limited | United Kingdom | |
| MSD Pharma (Singapore) Pte. Ltd. | Singapore | |
| MSD Pharma GmbH | Germany | |
| MSD Pharma Hungary Korlatolt Felelossegu Tarsasag | Hungary | |
| MSD Pharmaceuticals Private Limited | India | |
| MSD Polska Dystrybucja Sp. z.o.o. | Poland | |
| MSD Polska Sp.z.o.o. | Poland | |
| MSD R&D (China) Co., Ltd. | China | |
| MSD R&D Innovation Centre Limited | United Kingdom | |
| MSD Registry Holdings, Inc. | New Jersey | |
| MSD Row Holdings I B.V. | Netherlands | |
| MSD Shared Business Services EMEA Limited | Ireland | |
| MSD Sharp & Dohme Gesellschaft mit beschränkter Haftung | Germany | |
| MSD Switzerland Investments 4 Unlimited Company | Ireland | |
| MSD Ukraine Limited Liability Company | Ukraine | |
| MSD Vaccins | France | |
| MSD Vaccins Holdings | France | |
| MSD Venezuela Holding GmbH | Switzerland | |
| MSD Verwaltungs GmbH | Germany | |
| MSD Vietnam Holdings B.V. | Netherlands | |
| MSD Worldwide Holdings LLC | Delaware | |
| MSDIG Holdings Unlimited Company | Ireland | |
| MSDIG Holdings 2 Unlimited Company | Ireland | |
| MSP Vaccine Company 1 | Pennsylvania | |
| Multilan AG | Switzerland | |
| Nihon MSD G.K. | Japan | |
| Nourifarma - Produtos Quimicos e Farmaceuticos, Sociedade Unipessoal, Lda | Portugal | |
| O.PI.VI S.R.L. | Italy | |
| OBS Holdings B.V. | Netherlands | |
| Oncoethix GmbH | Switzerland | |
| OncoImmune, Inc. | Delaware | |
| OS ID AS | Norway | |
| OSID Stallmästaren AB | Sweden | |
| P.T. Merck Sharp & Dohme Indonesia | Indonesia | |
| Pandion Operations, Inc. | Delaware | |
| Pandion Therapeutics, Inc. | Delaware | |
| Peloton Therapeutics, Inc. | Delaware | |
| Polnet ID Spolka z ograniczona odpowiedzialnoscia | Poland | |
| PrognostiX-Poultry Limited | United Kingdom | |
| Prometheus Biosciences, Inc. | Delaware | |
| PT Intervet Indonesia | Indonesia | |
| Putexin Investments Limited | New Zealand | |
| Rigontec GmbH | Germany | |
| Rosetta Inpharmatics LLC | Delaware | |
| S.C.R. (Engineers) Limited | Israel | |
| Schering-Plough (Ireland) Unlimited Company | Ireland | |
| Schering-Plough Animal Health Limited | New Zealand | |
| Schering-Plough Canada Inc. | Canada | |
| Schering-Plough Corporation | Philippines | |
| Schering-Plough Corporation, U.S.A. | Delaware | |
| Schering-Plough Holdings Limited | United Kingdom | |
| Schering-Plough S.A. | Spain | |
| SCR Allflex Management, Ltd | Israel | |
| Shanghai MSD Pharmaceutical Trading Co., Ltd. | China | |
| Sistemas de Identificacao Animal Ltda | Brazil | |
| SmartCells, Inc. | Delaware | |
| SOL Limited | Bermuda | offshore centre |
| SureFlap Limited | United Kingdom | |
| Themis Bio Holdings LLC | Delaware | |
| Theriak B.V. | Netherlands | |
| Tilos Therapeutics, Inc. | Delaware | |
| Vaki Fiskeldiskerfi ehf. | Iceland | |
| VelosBio Inc. | Delaware | |
| VelosBio Canada Inc. | Canada | |
| Vence Corp | Delaware | |
| Vence Corp AU Pty Ltd | Australia | |
| Venco Holding GmbH | Switzerland | |
| Verona Pharma, Inc. | Delaware | |
| Verona Pharma Ireland Limited | Ireland | |
| Verona Pharma Ltd | United Kingdom | |
| Vet Pharma Friesoythe GmbH | Germany | |
| VetInvent, LLC | Delaware | |
| Vetrex B.V. | Netherlands | |
| Vetrex Egypt L.L.C. | Egypt | |
| Vol Holdings LLC | Delaware | |
| Vree Health Italia S.r.l. | Italy | |
| Werthenstein Biopharma GmbH | Switzerland | |
| Zoöpharm B.V. | Netherlands |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2020 | $48.0B | $7.1B | $5.6B | — | 2,541,000,000 |
| FY2021 | $48.7B | $13.0B | $8.7B | — | 2,538,000,000 |
| FY2022 | $59.3B | $14.5B | $14.7B | — | 2,542,000,000 |
| FY2023 | $60.1B | $365.0M | $9.1B | — | 2,547,000,000 |
| FY2024 | $64.2B | $17.1B | $18.1B | — | 2,541,000,000 |
| FY2025 | $65.0B | $18.3B | $12.4B | — | 2,507,000,000 |
12 institutions tracked — 6 added, 5 reduced, 1 opened a new position. Index money added 3,740,836 shares while active managers cut 13,510,254.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | Active fund | 46,718,520 | −8,674,563 | $6.0B |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 18,518,796 | −4,524,046 | $2.4B |
| CITADEL ADVISORS LLC | Hedge fund | 9,176,267 | −3,939,960 | $1.2B |
| VANGUARD GROUP INC | Index | 254,322,763 | +2,185,853 | $26.8B |
| WELLINGTON MANAGEMENT GROUP LLP | Active fund | 86,249,283 | +1,934,312 | $11.1B |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 60,744,214 | +1,186,060 | $7.8B |
| STATE STREET CORP | Index | 120,413,256 | +1,087,583 | $15.6B |
| MORGAN STANLEY | Active fund | 48,641,158 | +1,008,671 | $6.3B |
| FMR LLC | Active fund | 45,440,355 | +924,345 | $5.8B |
| BlackRock Finance, Inc. | Index | 208,209,717 | −718,660 | $25.8B |
| BANK OF AMERICA CORP /DE/ | Active fund | 30,535,208 | −239,013 | $3.9B |
NORGES BANK holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register. These filings span 2024-Q2–2026-Q2 rather than a single quarter, because filers report on their own schedules.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Merck & Co., Inc. files under SIC 2834 — all 50 pharmaceutical preparations companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
